Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

pneumococcal 20-valent conjugate vaccine

A pneumococcal conjugate vaccine containing 20 different strains of the bacterium Streptococcus pneumoniae, that is used for the prevention of pneumococcal disease. The pneumococcal 20-valent conjugate vaccine contains capsular antigen polysaccharides derived from the S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F that are individually conjugated to a nontoxic diphtheria cross-reactive material 197 (CRM197) carrier protein. Upon intramuscular vaccination, pneumococcal 20-valent conjugate vaccine induces active immunization against 20 different serotypes of S. pneumoniae and protects against pneumococcal disease.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:PCV 20 vaccine
US brand name:Prevnar 20
Code name:PCV 20
PCV20
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search